Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study.

Martín-Peláez S, Serra-Majem L, Cano-Ibáñez N, Martínez-González MÁ, Salas-Salvadó J, Corella D, Lassale C, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Fernández-Aranda F, Bueno-Cavanillas A, Tur JA, Martín V, Pintó X, Delgado-Rodríguez M, Matía P, Vidal J, Vázquez C, Daimiel L, Ros E, Toledo E, Nishi SK, Sorli JV, Malcampo M, Zulet MÁ, Moreno-Rodríguez A, Cueto-Galán R, Vivancos-Aparicio D, Colom A, García-Ríos A, Casas R, Bernal-López MR, Santos-Lozano JM, Vázquez Z, Gómez-Martínez C, Ortega-Azorín C, Del Val JL, Abete I, Goikoetxea-Bahon A, Pascual E, Becerra-Tomás N, Chillarón JJ, Sánchez-Villegas A.

Open source

DOI
10.1371/journal.pone.0265079
Published
2022-04-13
Container
PLoS One
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0265079,
  title = {Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study.},
  author = {Martín-Peláez S and  Serra-Majem L and  Cano-Ibáñez N and  Martínez-González MÁ and  Salas-Salvadó J and  Corella D and  Lassale C and  Martínez JA and  Alonso-Gómez ÁM and  Wärnberg J and  Vioque J and  Romaguera D and  López-Miranda J and  Estruch R and  Tinahones FJ and  Lapetra J and  Fernández-Aranda F and  Bueno-Cavanillas A and  Tur JA and  Martín V and  Pintó X and  Delgado-Rodríguez M and  Matía P and  Vidal J and  Vázquez C and  Daimiel L and  Ros E and  Toledo E and  Nishi SK and  Sorli JV and  Malcampo M and  Zulet MÁ and  Moreno-Rodríguez A and  Cueto-Galán R and  Vivancos-Aparicio D and  Colom A and  García-Ríos A and  Casas R and  Bernal-López MR and  Santos-Lozano JM and  Vázquez Z and  Gómez-Martínez C and  Ortega-Azorín C and  Del Val JL and  Abete I and  Goikoetxea-Bahon A and  Pascual E and  Becerra-Tomás N and  Chillarón JJ and  Sánchez-Villegas A.},
  year = {2022},
  journal = {PLoS One},
  doi = {10.1371/journal.pone.0265079},
  url = {https://doi.org/10.1371/journal.pone.0265079}
}

RIS

TY  - JOUR
TI  - Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study.
AU  - Martín-Peláez S
AU  -  Serra-Majem L
AU  -  Cano-Ibáñez N
AU  -  Martínez-González MÁ
AU  -  Salas-Salvadó J
AU  -  Corella D
AU  -  Lassale C
AU  -  Martínez JA
AU  -  Alonso-Gómez ÁM
AU  -  Wärnberg J
AU  -  Vioque J
AU  -  Romaguera D
AU  -  López-Miranda J
AU  -  Estruch R
AU  -  Tinahones FJ
AU  -  Lapetra J
AU  -  Fernández-Aranda F
AU  -  Bueno-Cavanillas A
AU  -  Tur JA
AU  -  Martín V
AU  -  Pintó X
AU  -  Delgado-Rodríguez M
AU  -  Matía P
AU  -  Vidal J
AU  -  Vázquez C
AU  -  Daimiel L
AU  -  Ros E
AU  -  Toledo E
AU  -  Nishi SK
AU  -  Sorli JV
AU  -  Malcampo M
AU  -  Zulet MÁ
AU  -  Moreno-Rodríguez A
AU  -  Cueto-Galán R
AU  -  Vivancos-Aparicio D
AU  -  Colom A
AU  -  García-Ríos A
AU  -  Casas R
AU  -  Bernal-López MR
AU  -  Santos-Lozano JM
AU  -  Vázquez Z
AU  -  Gómez-Martínez C
AU  -  Ortega-Azorín C
AU  -  Del Val JL
AU  -  Abete I
AU  -  Goikoetxea-Bahon A
AU  -  Pascual E
AU  -  Becerra-Tomás N
AU  -  Chillarón JJ
AU  -  Sánchez-Villegas A.
PY  - 2022
JO  - PLoS One
DO  - 10.1371/journal.pone.0265079
UR  - https://doi.org/10.1371/journal.pone.0265079
ER  -

APA

S, M., L, S., N, C., MÁ, M., J, S., D, C., C, L., JA, M., ÁM, A., J, W., J, V., D, R., J, L., R, E., FJ, T., J, L., F, F., A, B., JA, T., V, M., X, P., M, D., P, M., J, V., C, V., L, D., E, R., E, T., SK, N., JV, S., M, M., MÁ, Z., A, M., R, C., D, V., A, C., A, G., R, C., MR, B., JM, S., Z, V., C, G., C, O., JL, D. V., I, A., A, G., E, P., N, B., JJ, C., & A., S. (2022). Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study.. PLoS One. https://doi.org/10.1371/journal.pone.0265079

Source records